Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer prediction test based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.
Metrics to compare | ALPRE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALPREPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.9x | −2.2x | −0.5x | |
PEG Ratio | −5.04 | 0.09 | 0.00 | |
Price/Book | −0.9x | 1.4x | 2.6x | |
Price / LTM Sales | 24.9x | 4.0x | 3.3x | |
Upside (Analyst Target) | - | 132.0% | 38.9% | |
Fair Value Upside | Unlock | 11.1% | 5.4% | Unlock |